Pediatric Neurology
Volume 29, Issue 3 , Pages 236-238 , September 2003

Progressive muscle weakness after high-dose steroids in two children with CIDP

  • Kevin M Rostasy, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.
    • Corresponding Author InformationCommunications should be addressed to: Dr. Rostasy; Pediatric Neurology; Georg-August-University of Göttingen; Robert-Koch-Strasse 40; 37075 Göttingen, Germany.
    • ,
  • Katharina Diepold, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.
    • ,
  • Johannes Buckard, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.
    • ,
  • Knut Brockmann, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.
    • ,
  • Bernd Wilken, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.
    • ,
  • Folker Hanefeld, MD

      Affiliations

    • Department of Pediatrics and Neuropediatrics, Georg-August-Universität Göttingen, Göttingen, Germany.

Received 17 December 2002 ,Accepted 17 March 2003.

References 

  1. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children (II. Long-term follow-up, with comparison to adults). Muscle Nerve. 1997;20:1569–1575
  2. Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA. Childhood chronic inflammatory demyelinating polyneuropathy (Clinical course and long-term outcome). Neuromuscul Disord. 2000;10:398–406
  3. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics. 1999;30:190–196
  4. Nevo Y, Pestronk A, Kornberg AJ, et al.  Childhood chronic inflammatory demyelinating neuropathies (Clinical course and long-term follow-up). Neurology. 1996;47:98–102
  5. Molenaar DS, van Doorn PA, Vermeulen M. Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy (A pilot study). J Neurol Neurosurg Psychiatry. 1997;62:388–390
  6. Hughes RAC. Systematic reviews of treatment for inflammatory demyelinating neuropathy. J Anat. 2002;200:331–339
  7. Martinez-Caceres EM, Barrau MA, Brieva L, Espejo C, Barbera N. Treatment with methylprednisolone in relapses of multiple sclerosis patients (Immunological evidence in immediate and short-term but not long-lasting effects). Clin Exp Immunol. 2002;127:165–171
  8. Panegyres PK, Squier M, Mills KR, Newsom-Davis J. Acute myopathy associated with large parental dose of corticosteroid in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1993;56:702–704
  9. Witbrodt ET. Drugs and myasthenia. Arch Intern Med. 1997;157:399–408
  10. Larsson L, Li X, Edstrom L, et al.  Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids (Mechanisms at the cellular and molecular levels). Crit Care Med. 2000;28:34–45
  11. Mastaglia FL. Adverse effects of drugs on muscle. Drugs. 1982;24:304–321
  12. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S, Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve. 1987;10:428–438
  13. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vercuronium during steroid treatment. Muscle Nerve. 1991;14:1131–1139
  14. Dyck PJ, Sherman WR, Hallcher LM, et al.  Human diabetic endoneurial sorbitol, fructose and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8:590–596

PII: S0887-8994(03)00222-4

doi: 10.1016/S0887-8994(03)00222-4

Pediatric Neurology
Volume 29, Issue 3 , Pages 236-238 , September 2003

Article Tools

* Image Usage & Resolution